Evidence map›Paper›PMID 40774814›Full record

ArticleVox sanguinis2025

Onsite vasovagal reactions with and without loss of consciousness are distinct outcomes with different risk factors.

Christina Mikkelsen, Betina Samuelsen Sørensen, Bitten Aagaard, Sys Hasslund, Mie Topholm Bruun, Rune Larsen, Louise Ørnskov Drechsler, Maria Didriksen, Michael Schwinn, Joseph Dowsett and 9 more

Abstract read
In one paragraph

Article in Vox sanguinis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Christina MikkelsenDepartment of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.ORCID https://orcid.org/0000-0002-2945-6197
Betina Samuelsen SørensenDepartment of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark.
Bitten AagaardDepartment of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark.
Sys HasslundDepartment of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.
Mie Topholm BruunDepartment of Clinical Immunology, Odense University Hospital, Odense, Denmark.
Rune LarsenDepartment of Clinical Immunology, Zealand University Hospital, Køge, Denmark.ORCID https://orcid.org/0000-0002-7635-8012
Louise Ørnskov DrechslerDepartment of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.
Maria DidriksenDepartment of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.ORCID https://orcid.org/0000-0002-4856-496X
Michael SchwinnDepartment of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.ORCID https://orcid.org/0000-0002-6151-369X
Joseph DowsettDepartment of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
DBDS Genomic Consortium
Erik SørensenDepartment of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Christian ErikstrupDepartment of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.
Ole B PedersenDepartment of Clinical Immunology, Zealand University Hospital, Køge, Denmark.ORCID https://orcid.org/0000-0003-2312-5976
Niels GrarupNovo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Science, Copenhagen University, Copenhagen, Denmark.
Kari StefanssondeCODE genetics/Amgen Inc., Reykjavik, Iceland.
Morten Bagge HansenDepartment of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Torben HansenNovo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Science, Copenhagen University, Copenhagen, Denmark.
Sisse Rye OstrowskiDepartment of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Funding

Bio- and Genome Bank DenmarkDanish Administrative Regions 02/2611Danish Council for Independent Research 09-069412Danmarks Frie ForskningsfondNovo Nordisk Foundation NNF17OC0027594Novo Nordisk Foundation NNF17OC0027864Novo Nordisk Foundation NNF18CC0034900Novo Nordisk Foundation NNF23OC0082015Novo Nordisk Foundation NNF23SA0084103
6 · The paper itself

Abstract

BACKGROUND AND

objectivesVasovagal reactions (VVRs) are some of the most common adverse reactions (ARs) in blood donors. While researchers have tried to develop precise risk prediction tools, these studies have all combined onsite and offsite reactions as well as reactions with and without the loss of consciousness. This study aimed to investigate potential differences in risk phenotypes in onsite VVRs, here defined as syncope and near-fainting. MATERIALS AND

methodsWe included 40,543 participants from the Danish Blood Donor Study (136 syncope and 1453 near-fainting cases). Data on lifestyle and health were available from questionnaires. Data on donation type, time of day and ARs were available from the blood bank it-system. The risk of VVRs was assessed in a logistic mixed-effects model which included 345,751 donations. For genotyped participants (N = 21,102), polygenic scores were calculated for syncope, anxiety, neuroticism and cardiometabolic disease.

resultsRisk of both types of VVR was found to increase during warmer season and apheresis donation and reduce by donating late in the day. In addition, less donation experience and lower height increased the risk for near-fainting. In contrast, no donor-specific characteristics appeared to mediate the risk of syncope. Genetic predisposition of various traits had no effect on the risk of onsite VVRs.

conclusionThis study indicates that onsite syncope and near-fainting are distinct conditions with different risk profiles. Our findings emphasize the importance of a more detailed analysis of VVRs, suggesting that the common practice of combining VVR subtypes may reduce the accuracy of risk prediction.

Indexed as

Blood DonorsSyncope, VasovagalUnconsciousnessAdultDenmarkFemaleHumansMaleMiddle AgedRisk FactorsSyncopeblood donationdonor protectionhaemovigilancevasovagal reactions

Identifiers

PMID40774814
PMCPMC12422831

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.